Zika Update

More than 1.5 million childbearing women could be at risk of infection; pregnancy delays may be insufficient to prevent infection-related birth abnormalities; second study shows low risk of international spread due to Olympics; CDC updates prevention recommendations

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Map: projected number of Zika infections in childbearing womenUNIVERSITY OF SOUTHAMPTONBy the time the first wave of the current Zika outbreak is over, up to 1.65 million pregnant women in Central and South America could become infected with the virus, researchers from the WorldPop Project and Flowminder Foundation and their colleagues have estimated. In total, more than 90 million people could become infected throughout these regions and the Caribbean, with Brazil having more than three times the number of every other region, according to the team’s study, published today (July 25) in Nature Microbiology.

“These projections are an important early contribution to global efforts to understand the scale of the Zika epidemic, and provide information about its possible magnitude to help allow for better planning for surveillance and outbreak response, both internationally and locally,” study coauthor Andrew Tatem, director of WorldPop and the Flowminder Foundation, said in a statement. Estimates of the number of women at risk are complicated by the fact that up to 80 percent of infected people never show symptoms, Tatem added.

Another study suggests that merely delaying pregnancy may not be sufficient to reduce the risk of birth defects due to Zika virus infection, which has been linked to microcephaly and fetal death. Researchers from the Yale School of Public Health and colleagues modeled the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies